UBS analyst Michael Yee reiterated a Neutral rating and $27.00 price target on Pfizer (NYSE: PFE).The analyst commented, "PFE's Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE